Comment on «Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database»

Comment on «Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database»

Bibliographic Details
Main Author:	Henrique Cyrne Carvalho
Format:	Article
Language:	English
Published:	Elsevier 2012-07-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204912001146

Similar Items

Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction
by: Yong Hoon Kim, et al.
Published: (2021-06-01)

Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
by: Ting-Tse Lin, et al.
Published: (2018-04-01)

Adherence to Antiplatelet Therapy after Coronary Intervention among Patients with Myocardial Infarction Attending Vietnam National Heart Institute
by: Ngoc Minh Luu, et al.
Published: (2019-01-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
by: Dimitrios Alexopoulos, et al.
Published: (2020-11-01)

Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?
by: Hariri, Essa H.
Published: (2019)

Validation of DAPT score for prolonged dual antiplatelet therapy in patients with acute myocardial infarction
by: Daniel Veron-Esquivel, et al.
Published: (2019-09-01)

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
by: Daniel MF Claassens, et al.
Published: (2020-09-01)

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy
by: Christopher Reid, MD, et al.
Published: (2020-05-01)

Extended dual antiplatelet therapy after acute myocardial infarction. Current evidence and future perspectives
by: Nicola Cosentino, et al.
Published: (2019-07-01)

Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population
by: Gennaro Ratti, et al.
Published: (2021-09-01)

Dual antiplatelet therapy in myocardial infarction with non-obstructive coronary artery disease – insights from a nationwide registry
by: Fernando Montenegro Sá, et al.
Published: (2020-12-01)

Dual antiplatelet therapy in myocardial infarction with non-obstructive coronary artery disease – insights from a nationwide registry
by: Fernando Montenegro Sá, et al.
Published: (2020-12-01)

Effect of ticagrelor and clopidogrel on serum inflammatory factor level in antiplatelet therapy for acute myocardial infarction patients after percutaneous coronary intervention
by: Xiang-Ke Jia, et al.
Published: (2019-02-01)

Effect of acute coronary syndrome patients’ education on adherence to dual antiplatelet therapy
by: Hassan El-Toukhy, et al.
Published: (2017-10-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
by: Wang M, et al.
Published: (2015-09-01)

The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients
by: Borovyk K., et al.
Published: (2019-04-01)

Interaction of Panax quinquefolius Saponin and Dual Antiplatelets on Vascular Endothelial Function in Rats with Acute Myocardial Infarction
by: Baojun Wang, et al.
Published: (2015-01-01)

Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review
by: Becky Skidmore, et al.
Published: (2019-06-01)

Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion.
by: Seung Hwa Lee, et al.
Published: (2017-01-01)

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
by: Mei-Tzu Wang, et al.
Published: (2018-11-01)

Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.
by: Victor Chien-Chia Wu, et al.
Published: (2019-01-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
by: Morteza Safi, et al.
Published: (2009-01-01)

Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
by: Seyed Ahmad Hassantash, et al.
Published: (2009-03-01)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
by: Solheim Svein, et al.
Published: (2013-01-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01)

Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
by: Yoojin Noh, et al.
Published: (2016-01-01)

Cost analysis of dual antiplatelet therapy with prasugrel and ticagrelor in patients with acute coronary syndrome after percutaneous coronary intervention
by: I. N. Dyakov, et al.
Published: (2020-09-01)

Percutaneous transluminal coronary angioplasty in the right ventricle myocardial infarction treatment
by: Rafajlovski Saša I., et al.
Published: (2005-01-01)

Outcome of Primary Percutaneous Coronary Intervention in Octogenarians with Acute Myocardial Infarction
by: Yi-Chih Wang, et al.
Published: (2006-01-01)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
by: Gao L, et al.
Published: (2014-07-01)

Aborted myocardial infarction in patients undergoing primary percutaneous coronary intervention
by: Małgorzata Pyda, et al.
Published: (2015-03-01)

Dual Antiplatelet Therapy in Coronary Artery Disease
by: Raghav Sharma, et al.
Published: (2020-08-01)

Mandated Health Insurance and Provider Reimbursement via Private Insurance
by: Andrew Friedson, et al.
Published: (2017-01-01)

APPLICABILITY OF FULL MEDICAL EXPENSE REIMBURSEMENT INSURANCE IN DOUBLE INSURANCE
by: Ching-Chung Huang, et al.
Published: (2015)

Management of non-ST-elevation myocardial infarction: A constant challenge
by: Henrique Cyrne Carvalho
Published: (2016-12-01)

Corrected thrombolysis in myocardial infarction frame count and ejection fraction in patients undergoing primary percutaneous coronary intervention for myocardial infarction
by: Hossein Vakili, et al.
Published: (2013-03-01)

Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01)